2026 Specialty Measure Set

2026 MIPS Quality Measures for Infectious Disease

The 15 MIPS quality measures designated by CMS for the Infectious Disease specialty set. These are the measures infectious disease specialists are most likely to report on—though any MIPS-eligible measure can be submitted.

15measures
7high priority
12with benchmarks
5topped out
ID Measure eCQMType Status
MIPS 065Appropriate Treatment for Upper Respiratory Infection (URI)CMS154v14High PriorityTopped Out
MIPS 066Appropriate Testing for PharyngitisCMS146v14High PriorityTopped Out
MIPS 130Documentation of Current Medications in the Medical RecordCMS68v15High PriorityTopped Out
MIPS 176Tuberculosis Screening Prior to First Course of Biologic and/or Immune ResponseProcessTopped Out
MIPS 205Sexually Transmitted Infection (STI) Testing for People with HIVCMS1188v3ProcessBenchmark
MIPS 226Preventive Care and Screening: Tobacco Use: Screening and CessationCMS138v14ProcessTopped Out
MIPS 338HIV Viral SuppressionCMS314v3High PriorityBenchmark
MIPS 340HIV Annual Retention in CareCMS1157v2High PriorityBenchmark
MIPS 387Annual Hepatitis C Virus (HCV) Screening for Patients who are Active Injection Drug UsersProcessBenchmark
MIPS 394Immunizations for AdolescentsProcessBenchmark
MIPS 493Adult Immunization StatusProcessBenchmark
MIPS 503Gains in Patient Activation Measure (PAM) Scores at 12 MonthsHigh PriorityBenchmark
MIPS 516Hepatitis C Virus (HCV): Sustained Virological Response (SVR)High Priority

All Specialty Sets

Need help selecting measures?

VBCA's clinical policy team helps practices choose the right measure mix based on patient population, benchmark opportunity, and program requirements.

Talk to Us →